It belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists
Hand, feet, and ankle swelling
METHOD Design This cross-sectional study consisted of an online questionnaire, distributed by an individual-participant-generated (unique) link using Select Survey
Nausea and Upset Stomach: Some individuals may experience nausea, upset stomach, or gastrointestinal discomfort after receiving MIC+B12 injections
Last Updated on April 22, 2026 When normal soreness and real warning signs are not the same thing See which post-injection symptoms usually settle quickly and which ones deserve prompt follow-up

Potential benefits of using GLP-1 receptor agonists after gastric sleeve surgery include: Enhanced weight loss : Observational studies suggest post-bariatric patients using GLP-1 receptor agonists may achieve additional weight reduction, typically around 510% of body weight, though individual responses vary considerably Improved glycaemic control : Particularly beneficial for patients with type 2 diabetes or prediabetes, as GLP-1 agonists enhance insulin secretion and reduce blood glucose levels Reduced appetite : These medications can help patients who struggle with persistent hunger despite surgical intervention Cardiovascular benefits : Semaglutide has demonstrated cardiovascular risk reduction in people with established cardiovascular disease, which may benefit eligible post-bariatric patients with this specific risk profile Maintenance of weight loss : May help prevent weight regain during the critical maintenance phase Potential risks and considerations include: Gastrointestinal side effects : Nausea, vomiting, diarrhoea, and constipation are common, particularly during dose escalation
